{
  "id": 11183122,
  "title": "Helus Pharma Announces Completion of Legal Name Change",
  "url": "https://urgent.news/2026/10/01/helus-pharma-announces-completion-of-legal-name-change",
  "topic": "business",
  "section": "Business",
  "published": "2026-10-01T11:36:31.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/helus-pharma-announces-completion-of-legal-name-change"
  },
  "original_language": "en",
  "account": null,
  "summary": "NEW YORK and TORONTO, Oct. 01, 2026 (GLOBE NEWSWIRE) — Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP) (“Helus” or the “Company”), a clinical-stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (“NSAs”), is pleased to announce the Company’s legal name has been changed from “Cybin Inc.” to “Helus Pharma Inc.” effective […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}